Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)

Naomi Aronson*, Barbara L. Herwaldt, Michael Libman, Richard Pearson, Rogelio Lopez-Velez, Peter Weina, Edgar M. Carvalho, Moshe Ephros, Selma Jeronimo, Alan Magill

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

208 Scopus citations

Abstract

Guidelines for the clinical management of persons with leishmaniasis were prepared by a Panel of the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). The guidelines are intended for internists, pediatricians, family practitioners, and dermatologists, as well as infectious disease specialists, practicing in the United States and Canada (for simplicity, referred to here as North America). The Panel followed a guideline development process that has been adopted by IDSA, which includes a systematic method of grading both the quality of evidence (very low, low, moderate, or high) and the strength of the recommendation (weak or strong) [1] (Figure 1).

Original languageEnglish
Pages (from-to)24-45
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume96
Issue number1
DOIs
StatePublished - Jan 2017

Keywords

  • cutaneous leishmaniasis
  • immunocompromised host
  • leishmaniasis diagnostic testing
  • mucosal leishmaniasis
  • visceral leishmaniasis

Fingerprint

Dive into the research topics of 'Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH)'. Together they form a unique fingerprint.

Cite this